BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37382008)

  • 21. Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: A mechanism review.
    Shi X; Chang M; Zhao M; Shi Y; Zhang Y
    Biomed Pharmacother; 2022 Dec; 156():113916. PubMed ID: 36411609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
    Jin X; Dong W; Chang K; Yan Y
    J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury.
    Teh YM; Mualif SA; Lim SK
    Int J Biochem Cell Biol; 2022 Feb; 143():106153. PubMed ID: 34974186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
    Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
    Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
    J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
    Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research.
    Lin L; Tian E; Ren J; Wu Z; Deng J; Yang J
    Front Pharmacol; 2022; 13():932739. PubMed ID: 36003509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
    Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
    Lovric S; Ashraf S; Tan W; Hildebrandt F
    Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
    Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
    Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
    Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.
    Liu Y; Jiang B; Li Y; Zhang X; Wang L; Yao Y; Zhu B; Shi H; Chai X; Hu X; Zhang B; Li H
    Medicine (Baltimore); 2024 Jan; 103(3):e36467. PubMed ID: 38241548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of TGF-β/Smad signaling pathway in diabetic kidney disease and research progress of traditional Chinese medicine intervention].
    Chen YX; Jiang XX; Zhang QY; Xu CQ; Hu YM; Jin CY; Zhang BL; Fu YQ; Jin ZS
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2630-2638. PubMed ID: 37282924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway.
    Lin H; Chen H; Qian R; Tang G; Ding Y; Jiang Y; Chen C; Wang D; Chu M; Guo X
    Chem Biol Interact; 2023 Sep; 382():110559. PubMed ID: 37247809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of podocyte genes in children with sporadic steroid-resistant nephrotic syndrome.
    Feng DN; Yang YH; Wang DJ; Meng DC; Fu R; Wang JJ; Yu ZH
    Genet Mol Res; 2014 Nov; 13(4):9514-22. PubMed ID: 25501161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of the EP2 receptor on TGF-β1 induced podocyte injury via the PI3K / Akt signaling pathway.
    Liu J; Zhang YD; Chen XL; Zhu XL; Chen X; Wu JH; Guo NF
    PLoS One; 2018; 13(5):e0197158. PubMed ID: 29746568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of tonifying kidney and activating blood therapy for premature ovarian failure:a review].
    Ma K; Li JN; Fan XD; Zhang H; Ma LN
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1808-1814. PubMed ID: 37282955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.